ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Sandoz Group Ag

Sandoz Group Ag (0SAN)

0.00
0.00
(0.00%)
終了 2月6日 1:30AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
-
買値
0.00
売値
0.00
出来高
34,031
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
0.00
始値
-
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
0.00
配当利回り
-
PER
0.00
1 株当たり利益 (EPS)
-
歳入
9.65B
純利益
77M

Sandoz Group Ag について

セクター
Med, Dental, Hosp Eq-whsl
業界
Med, Dental, Hosp Eq-whsl
ウェブサイト
本社
Rotkreuz, Che
設立
-
Sandoz Group Ag is listed in the Med, Dental, Hosp Eq-whsl sector of the ロンドン証券取引所 with ticker 0SAN. The last closing price for Sandoz was CHF0. Over the last year, Sandoz shares have traded in a share price range of CHF 0.00 to CHF 0.00.

Sandoz currently has 0 shares in issue.

0SAN 最新ニュース

Francisco Ballester to retire; Peter Stenico appointed President Region International

Francisco Ballester to retire; Peter Stenico appointed President Region International Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules President Region International...

Sandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare Conference

Sandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare Conference MEDIA RELEASE Strong first year as standalone company; global leader Sandoz...

Sandoz takes further steps to resolve legacy US Generic Drug Antitrust Class Action Litigation

Sandoz takes further steps to resolve legacy US Generic Drug Antitrust Class Action Litigation Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz takes further steps...

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio MEDIA RELEASE Afqlir® (aflibercept) approved to treat various retinal...

Sandoz reports third-quarter and nine-month 2024 sales

Sandoz reports third-quarter and nine-month 2024 sales Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong third-quarter biosimilars growth of 37% in...

Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar position

Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar position Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Enzeevu™...

Sandoz reports second-quarter sales and half-year 2024 results

Sandoz reports second-quarter sales and half-year 2024 results Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong double-digit growth in biosimilars of...

Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases

Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz launches...

FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US

FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules FDA approves biosimilar...

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe   Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0SAN - Frequently Asked Questions (FAQ)

What is the current Sandoz share price?
The current share price of Sandoz is CHF 0.00
What is the 1 year trading range for Sandoz share price?
Sandoz has traded in the range of CHF 0.00 to CHF 0.00 during the past year
What is the reporting currency for Sandoz?
Sandoz reports financial results in USD
What is the latest annual turnover for Sandoz?
The latest annual turnover of Sandoz is USD 9.65B
What is the latest annual profit for Sandoz?
The latest annual profit of Sandoz is USD 77M
What is the registered address of Sandoz?
The registered address for Sandoz is SUURSTOFFI 14, ROTKREUZ, ROTKREUZ, 6343
What is the Sandoz website address?
The website address for Sandoz is www.sandoz.com
Which industry sector does Sandoz operate in?
Sandoz operates in the MED, DENTAL, HOSP EQ-WHSL sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
GFINGfinity Plc
0.095p
(72.73%)
576.77M
XSGXeros Technology Group Plc
0.70p
(33.33%)
23.5M
OMIOrosur Mining Inc
9.55p
(29.93%)
11.76M
SNGSynairgen Plc
2.49p
(27.86%)
229.83k
IKAIlika Plc
34.25p
(26.85%)
1.91M
WBIWoodbois Limited
0.0525p
(-36.36%)
546.31M
CRVCraven House Capital Plc
US$ 0.275
(-26.67%)
49.99k
KRPZKropz Plc
0.85p
(-26.09%)
432.89k
MACMarechale Capital Plc
2.35p
(-24.19%)
26.92M
TRCThe Revel Collective Plc
0.175p
(-22.22%)
5.52M
NTVONativo Resources Plc
0.0017p
(0.00%)
2.07B
GFINGfinity Plc
0.095p
(72.73%)
576.77M
WBIWoodbois Limited
0.0525p
(-36.36%)
546.31M
OBDOxford Biodynamics Plc
0.55p
(10.00%)
373.53M
MSMNMosman Oil And Gas Limited
0.04p
(-8.05%)
338.97M

最近閲覧した銘柄

Delayed Upgrade Clock